Caricamento...
Ticagrelor-Induced Prolongation of the QTc Interval
BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...
Salvato in:
| Pubblicato in: | Case Rep Cardiol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/ https://ncbi.nlm.nih.gov/pubmed/31827937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|